NIAID
Through Agency-Funded Contractors, NIAID Aims to Help Bring Infectious Disease Tests to Market
Premium
The Diagnostics Development Services program is, so far, being used to help point-of-care testing firm Fluxergy bring to market a test for sexually transmitted infections.
NIH Awards $2.4M to Improve Syphilis Diagnostics
The 10 awards cover different novel diagnostic approaches as well as biomarker discovery and pre-analytical methods.
Day Zero Diagnostics Wins $300K SBIR Grant for Fecal Microbiota Transplant Assay
The Boston firm will develop a sequencing-based safety and efficacy assay for fecal microbiota transplants called epiXact FMT.
Phase Genomics Wins $5.5M in NIH, Gates Foundation Grants for Therapeutic Phage Discovery
The company will use its proximity-guided metagenomics platform to build an atlas of phage-bacteria interactions and identify phages that could be used therapeutically.
UCSF-led Team Wins $112M NIH Grant to Harness Omics Tools for Antiviral Target, Drug Development
Premium
The researchers will use a variety of omics tools, including a protein-protein interaction workflow they previously employed to look for drugs against SARS-CoV-2.